[Ketanserin and metoprolol in the treatment of essential hypertension].
In a controlled clinical study, 30 adult patients (16 females, 14 males, mean age 46.0 +/- 7.6, mean body weight 69.4 +/- 10.2 kg) with mild-moderate essential hypertension were treated with ketanserin (20 mg twice daily) or metoprolol (100 mg daily) for the first month and 40 mg twice daily or 100 mg twice daily during the second month. Results showed antihypertensive efficacy and systemic tolerability of ketanserin to be equal to that of metoprolol and better cardiac tolerance for ketanserin.
Cerasola
G
G
Cattedra di Fisiologia Respiratoria, Università degli Studi di Palermo.
Contorno
A
A
D'Ignoto
G
G
Talamo
A R
AR
Vallone
A
A
Zilietti
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007650:Ketanserin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008790:Metoprolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D013997:Time Factors
D007650:Ketanserin; D008790:Metoprolol
Ketanserina e metoprololo nel trattamento dell'ipertensione essenziale.